Advertisement

Specialty News

July 01, 2015
June 26, 2015
Hepatitis C has recently come to the forefront of the medical community, mostly because of the controversial cost of the newest drug therapies used...
Many patients have questions about hepatitis C
MORE
July 01, 2015
June 26, 2015
No matter the pharmacy practice area, technicians play a significant role in the dispensing process. As the pharmacist’s role within patient care...
As the pharmacist's role within patient care expands, so too does the technician's.
MORE
July 01, 2015
June 26, 2015
While the adverse effects of chemotherapy are well known, cognitive impairment—also known as “chemo brain” or “chemo fog”—has only recently gained...
Integrative Medicine
MORE
April 01, 2015
March 31, 2015
FDA has approved blinatumomab (Blincyto—Amgen) for the treatment of patients with Philadelphia chromosome–negative B-cell precursor acute...
New Drug
MORE
April 01, 2015
March 30, 2015
FDA has approved lenvatinib (Lenvima—Eisai), a new oral treatment option for patients with locally recurrent or metastatic differentiated thyroid...
New Drug
MORE
April 01, 2015
March 30, 2015
Panobinostat (Farydak—Novartis) received accelerated FDA approval to treat patients with multiple myeloma who have received at least two prior...
New Drug
MORE
April 01, 2015
March 30, 2015
On March 6, FDA approved the first biosimilar product for U.S. patients, filgrastim-sndz (Zarxio—Sandoz). Approval was based on its similarity to...
Zarxio was approved based on its similarity to Neupogen
MORE
April 01, 2015
March 27, 2015
Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system (CNS) affecting the brain, spinal cord, and optic nerves. In...
Specialty Pharmacy Section
MORE
December 01, 2014
November 25, 2014
Ledipasvir and sofosbuvir (Harvoni—Gilead), a newly approved once-daily oral combination tablet, is being touted as a “game changer” by many...
New Drug
MORE
September 01, 2014
August 22, 2014
Idelalisib (Zydelig—Gilead Sciences), an oral therapy for the treatment of three B-cell blood cancers, has received FDA approval. The new drug...
New Drug
MORE

Pages